- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02488317
Empowering Patients On Choices for Renal Replacement Therapy (Aim 3) (EPOCH-RRT) (EPOCH-RRT)
Empowering Patients On Choices for Renal Replacement Therapy (Aim 3)
Empowering Patients On Choices for Renal Replacement Therapy (EPOCH-RRT) study seeks to identify factors that matter the most to patients with kidney disease and study how they are impacted by different types of dialysis. The inclusion of patients, caregivers, and patient advocacy organizations as research partners will assure that the study addresses questions of greatest relevance to patients facing the need for dialysis.
For Aim 3, the investigators are going to compare measures related to the decision-making process between patients receiving and not receiving a decision aid focusing on Peritoneal Dialysis and Hemodialysis.
Study Overview
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Michigan
-
Ann Arbor, Michigan, United States, 48104
- Arbor Research Collaborative for Health
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- 18 years and older
- Speaks English
- Has access to the internet
Exclusion Criteria:
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: Intervention arm
These patients will receive the decision aid tool.
Decision-making outcomes (e.g., self-efficacy) will be compared between patients who received and did not receive a decision aid.
These arms were chosen because the current standard of care is for health care providers to discuss options with patients without using a decision aid.
|
Decision-making outcomes (e.g., self-efficacy) will be compared between patients who received and did not receive a decision aid.
These arms were chosen because the current standard of care is for health care providers to discuss options with patients without using a decision aid.
|
No Intervention: Control arm
These patients will not receive the decision aid tool and will be asked to test their knowledge without it.
Decision-making outcomes (e.g., self-efficacy) will be compared between patients who received and did not receive a decision aid.
These arms were chosen because the current standard of care is for health care providers to discuss options with patients without using a decision aid.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Preference for Shared Decision Making
Time Frame: 6 months
|
Measured using the scale from Degner, L. F., Sloan, J. A., & Venkatesh, P. (1996).
The Control Preferences Scale.
The Canadian journal of nursing research= Revue canadienne de recherche en sciences infirmieres, 29(3), 21-43.
The CPS is a clinically relevant, easily administered, valid, and reliable measure of preferred roles in health-care decision-making.
A pick-one approach was used to identify patient preference for an active, passive or collaborative role in dialysis treatment decision making.
|
6 months
|
Decisional Conflict
Time Frame: 6 months
|
Measured using the scale from O'Connor, Annette M. "Validation of a Decisional Conflict Scale."
Medical Decision Making 15, no. 1 (February 1, 1995): 25-30.
16 item scale, responses to each statement are scored from 1 (strongly agree) to 5 (strongly disagree), with negative statements having reverse scoring; thus high scores indicate higher decisional conflict.
Mean score per participant is calculated across all items, subtract by 1 and multiplied by 25.
Score range= 0-100.
Mean scores across all participants in each arm are reported.
|
6 months
|
Decision Self-efficacy
Time Frame: 6 months
|
Measured through the scale found in Decision Self-Efficacy Ottawa: Ottawa Hospital Research Institute; © 1995 Available from: http://decisionaid.ohri.ca/docs/develop/User_Manuals/UM_Decision_SelfEfficacy.pdf
O'Connor 1995 Items are scored 0(not at all confident) to 4 (very confident).
Scores are summed across 10 items, divided by 10 and multiplied by 25.
Scores range from 0-100.
A score of 0 means "extremely low self efficacy" and a score of 100 means "extremely high self efficacy".
|
6 months
|
Knowledge
Time Frame: 6 months
|
Measured using scale from Cavanaugh K"Patient Dialysis Knowledge Is Associated with Permanent Arteriovenous Access Use in Chronic Hemodialysis."
Clinical Journal of the American Society of Nephrology 4, no.
5: 950-56) Multiple choice questions with one correct answer per questions.
Number of correct questions reported as a percentage of total number of questions (23).
|
6 months
|
Preparation for Decision Making
Time Frame: 6 months
|
Measured using Bennett, Carol, "Validation of a Preparation for Decision Making Scale."
Patient Education and Counseling 78, no.
1: 130-33 10 item scale, each item scored from 1 (not at all) to 5 (a great deal).
items are summed and scored, converted to a 0-100 scale by subtracting 1 from the summed score and multiplying by 25.
Higher scores indicate higher perceived level of preparation for decision making.
|
6 months
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Francesca Tentori, MD, MS, Arbor Research Collaborative for Health
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1109201303123
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Kidney Disease
-
3-C Institute for Social DevelopmentUniversity of North Carolina, Chapel HillCompletedChronic Kidney Diseases | Chronic Kidney Disease Stage 5 | Chronic Kidney Disease stage4 | Pediatric Kidney Disease | Chronic Kidney Disease stage3 | Chronic Kidney Disease Stage V | Chronic Kidney Disease, Stage IV (Severe) | Chronic Kidney Disease Stage 2 | Chronic Kidney Disease, Stage IUnited States
-
Universiti Putra MalaysiaRecruitingChronic Kidney Diseases | Chronic Kidney Disease Stage 5 | Chronic Kidney Disease stage4 | Chronic Kidney Disease stage3 | Chronic Kidney Disease Requiring Chronic DialysisMalaysia
-
National Taiwan University HospitalCompletedChronic Kidney Disease stage4 | Chronic Kidney Disease stage3 | Chronic Kidney Disease Stage 2 | Chronic Kidney Disease Stage 1Taiwan
-
Centre Hospitalier le MansLe Mans UniversiteWithdrawnFatigue | Chronic Kidney Disease Stage 5 | Chronic Kidney Disease stage3 | Chronic Kidney Failure | Chronic Kidney Disease, Stage 4 (Severe)
-
Centre Hospitalier le MansLe Mans UniversiteRecruitingFatigue | Chronic Kidney Disease Stage 5 | Chronic Kidney Disease stage4 | Chronic Kidney Disease Stage 3BFrance
-
American Academy of Family PhysiciansUniversity of Colorado, Denver; National Institute of Diabetes and Digestive... and other collaboratorsCompletedChronic Kidney Disease | Chronic Renal Insufficiency | Chronic Kidney Insufficiency | Chronic Renal Diseases | Kidney Insufficiency, ChronicUnited States
-
Lund UniversityBaxter Healthcare Corporation; Universidad de CórdobaCompletedEnd Stage Kidney Disease | Chronic Kidney Disease Requiring Chronic DialysisArgentina
-
Centre Hospitalier Saint Joseph Saint Luc de LyonNot yet recruitingKidney Failure, Chronic | Diet Habit | Chronic Kidney Disease stage3 | Chronic Kidney Disease Stage 3B | Chronic Kidney Disease, Stage 3 (Moderate) | Chronic Kidney Disease Stage 3A (Disorder)France
-
A.C. AbrahamsCompletedEnd Stage Renal Disease | Chronic Kidney Disease | End Stage Kidney Disease | Chronic Kidney FailureNetherlands
-
Far Eastern Memorial HospitalActive, not recruitingMetabolic Syndrome | Chronic Disease | Chronic Kidney Disease Stage 5 | Chronic Kidney Disease Stage 3 | Chronic Kidney Disease Stage 4 | Chronic Kidney Disease Stage 2 | Chronic Kidney Disease Stage 1Taiwan
Clinical Trials on Decision Aid
-
University of LeedsBaxter Healthcare Corporation; National Health Service, United Kingdom; Foundation... and other collaboratorsCompletedChronic Kidney FailureUnited Kingdom
-
Massachusetts General HospitalCompletedCoronary Artery Disease | Stable AnginaUnited States
-
University Hospital HeidelbergInnovationsfonds des Gemeinsamen Bundesausschusses, GermanyCompletedPatient Decision Aid | Treatment As UsualGermany
-
Massachusetts General HospitalUnknownDecision Making | Video Decision AidsUnited States
-
Kaiser PermanenteFoundation for Informed Medical Decision MakingCompletedObesity | Obesity, Morbid | Bariatric Surgery | Decision AidsUnited States
-
Case Comprehensive Cancer CenterCompletedProstate CancerUnited States
-
Duke UniversityFoundation for Informed Medical Decision MakingCompletedOsteoarthritisUnited States
-
University of UtahPatient-Centered Outcomes Research Institute; Mayo Clinic; Northwestern University and other collaboratorsActive, not recruitingAtrial FibrillationUnited States
-
University of MichiganNational Cancer Institute (NCI)Completed
-
Massachusetts General HospitalCompleted